AGES:LSE:LSE-iShares IV Public Limited Company - iShares Ageing Population UCITS ETF (GBX)

ETF | Others |

Last Closing

USD 544.5

Change

+2.00 (+0.37)%

Market Cap

USD 0.50B

Volume

0.02M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-04-18 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
0R15:LSE SoftBank Group Corp.

+8.00 (+0.10%)

USD 9,217.80B
0R1E:LSE Nintendo Co. Ltd.

-145.00 (-1.88%)

USD 7,596.04B
0R1O:LSE Amazon.com Inc.

+3.75 (+2.11%)

USD 1,607.29B
0R1I:LSE NVIDIA Corp.

+20.55 (+2.48%)

USD 618.20B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

+0.21 (+1.52%)

USD 617.54B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

+0.24 (+1.42%)

USD 617.54B
0R1G:LSE Home Depot Inc.

N/A

USD 373.16B
XDJP:LSE Xtrackers Nikkei 225 UCITS ETF..

+38.75 (+1.94%)

USD 348.03B
0QZK:LSE Coca-Cola Co.

-0.15 (-0.24%)

USD 266.08B
0QZO:LSE 0QZO

N/A

USD 258.54B

ETFs Containing AGES:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -0.73% 37% F 45% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -0.73% 35% F 44% F
Trailing 12 Months  
Capital Gain 2.18% 39% F 50% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 2.18% 36% F 48% F
Trailing 5 Years  
Capital Gain 22.65% 49% F 60% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 22.65% 46% F 57% F
Average Annual (5 Year Horizon)  
Capital Gain 4.87% 54% F 60% D-
Dividend Return 4.87% 53% F 59% D-
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 13.46% 54% F 69% C-
Risk Adjusted Return 36.16% 58% F 70% C-
Market Capitalization 0.50B 71% C- 60% D-

Annual Financials (GBX)

Quarterly Financials (GBX)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike